|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61M 5/315 | (2006.01) |
| A61M 5/28 | (2013.01) | ||
| A61M 5/28 | (2006.01) | ||
| A61M 5/3137 | (2013.01) | ||
| A61M 5/31 | (2006.01) | ||
| A61M 5/31505 | (2013.01) | ||
| A61M 5/31513 | (2013.01) | ||
| A61M2005/3104 | (2013.01) | ||
| A61M2005/3139 | (2013.01) | ||
| A61M2005/31508 | (2013.01) | ||
| A61M 5/001 | (2013.01) | ||
| Y10T 29/49826 | (2015.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3858405 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21164847.2 |
| Date of filing the European patent application | 2013-05-30 | |
| (97) | Date of publication of the European application | 2021-08-04 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-05 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 12170628 | 2012-06-01 | EP |
| (72) |
BRYANT, Andrew , CH
BUETTGEN, Heinrich , CH
PAPST, Wolfgang , CH
PICCI, Marie , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | SYRINGE |
| SYRINGE |